News
These healthcare leaders still could perform well in the long run. Novo Nordisk has been facing several challenges that ...
Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...
Eli Lilly and Company (NYSE:LLY) is among the 12 Best Ethical Companies to Invest in 2025. Eli Lilly and Company (NYSE:LLY) ...
Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...
Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...
7hon MSNOpinion
For RFK Jr. and his antivax supporters and associates, aluminum adjuvants in some required children’s vaccines appear to be ...
Explore more
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks.
Miah’s decade-long battle to be at peace with her body – which she says is due to health concerns rather than body image – has seen her explore a rollercoaster of weightloss methods, from fad diets to ...
This article delves into the approved weight loss drugs in India, their costs, and the growing market for such medications.
The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results